|
|
Volumn 9, Issue 2, 2007, Pages 81-83
|
|
Renin inhibition: The next step in suppression of the renin-angiotensin system?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALDOSTERONE ANTAGONIST;
ALISKIREN;
AMLODIPINE;
ANGIOTENSIN 2 RECEPTOR ANTAGONIST;
ANGIOTENSIN I;
ANGIOTENSIN II;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
HYDROCHLOROTHIAZIDE;
IRBESARTAN;
LOSARTAN;
MITOGEN ACTIVATED PROTEIN KINASE;
MITOGEN ACTIVATED PROTEIN KINASE 1;
PRORENIN;
RAMIPRIL;
RENIN;
RENIN INHIBITOR;
TRANSFORMING GROWTH FACTOR BETA1;
VALSARTAN;
ANTIHYPERTENSIVE ACTIVITY;
CHRONIC KIDNEY DISEASE;
CLINICAL TRIAL;
DIABETIC NEPHROPATHY;
DOSE RESPONSE;
DRUG BIOAVAILABILITY;
DRUG HALF LIFE;
DRUG MEGADOSE;
DRUG POTENTIATION;
HUMAN;
HYPERTENSION;
IC 50;
MONOTHERAPY;
NONHUMAN;
NOTE;
PROTEIN EXPRESSION;
PROTEIN LOCALIZATION;
RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;
ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
BLOOD PRESSURE;
CARDIOVASCULAR DISEASES;
HUMANS;
RENIN;
RENIN-ANGIOTENSIN SYSTEM;
|
|
EID: 34249072235
PISSN: 15226417
EISSN: None
Source Type: Journal
DOI: 10.1007/s11906-007-0014-6 Document Type: Note |
|
Times cited : (4)
|
|
References (0)
|
